Intellia Therapeutics, Inc.

This role drives the strategy, implementation, and continuous improvement of Quality Management Systems (QMS) and digital compliance platforms, serving as the subject matter expert for Veeva Quality Vault and related GxP systems. Responsibilities include supporting Document Control, driving continuous improvement, executing Computer System Validation (CSV) activities, and leading change management initiatives for system adoption.

The Senior Medical Director will lead the development and execution of a comprehensive US and global Medical Affairs strategy to support the launch of the lonvoguran ziclumeran (NTLA-2002) hereditary angioedema program, focusing on KOL engagement, real-world evidence generation, internal expertise, and healthcare systems strategy. Primary duties involve driving strategic engagement with key stakeholders, collaborating on evidence generation plans, serving as the in-house subject matter expert, and partnering on post-marketing accessibility.

This role involves leading the Medical Affairs strategy and execution for the NTLA-2001 ATTR amyloid polyneuropathy program, including developing and driving engagement plans with key stakeholders like advocacy groups, societies, and payers. The Senior Medical Director is also accountable for the operational oversight of plan execution and ensuring medical accuracy in all communications.